Compare Moderna, Inc. (MRNA) vs MasTec Inc (MTZ) Price & Performance

Moderna, Inc.Trade

MasTec IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs MasTec Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while MasTec Inc trades at $350.55 (market cap $26.60B). The key difference: Moderna, Inc. and MasTec Inc are close in size by market cap. Which is the better fit depends on your goals.

	MRNA	MTZ
Market Cap	$23.60B	$26.60B
Sector	Health	Technology
52-Week High	$81.80	$437.51
52-Week Low	$22.36	$172.51
Enterprise Value	$19.70B	$29.34B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

MTZ

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About MasTec Inc

MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.